Asthma drug found to block coronavirus from replicating: IISc Bengaluru study - A study conducted by IISc Bengaluru shows that a drug used to treat asthma can help block SARS-CoV-2 protein from replicating.
An antiallergic drug named Montelukast, which is commonly used to treat asthma, hay fever and hives, can be helpful in managing Covid-19 infection, researchers at the Indian Institute of Science (IISc) have indicated.
A drug used to treat asthma and allergies can bind to and block a crucial protein produced by the virus SARS-CoV-2, and reduce viral replication in human immune cells, according to a new study by researchers at the Indian Institute of Science .